CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 63,409 shares at $24.65 ($1.6M) on 2017-12-14, disclosed to the SEC on 2017-12-15.
Open-market purchase of $1.6M RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.65 | 6,245 | $154K | 9.8% |
| 2 | $24.65 | 19,672 | $485K | 31.0% |
| 3 | $24.65 | 37,492 | $924K | 59.1% |
| Total | $24.65 avg | 63,409 | $1.6M | 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |